We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00516412
Recruitment Status : Completed
First Posted : August 15, 2007
Last Update Posted : September 29, 2015
Sponsor:
Information provided by (Responsible Party):
Swiss Group for Clinical Cancer Research